EX-FILING FEES 6 d919294dexfilingfees.htm EX-FILING FEES EX-FILING FEES

Exhibit 107

Calculation of Filing Fee Tables

Form S-3

(Form Type)

Fractyl Health, Inc.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered and Carry Forward Securities

 

                         
     Security
Type
  Security
Class
Title
  Fee
Calculation
or Carry
Forward
Rule
 

Amount

Registered 

  Proposed
Maximum
Offering
Price Per
Unit
  Maximum
Aggregate
Offering
Price
  Fee
Rate
  Amount of
Registration
Fee
 

Carry

Forward 

Form

Type

 

Carry

Forward 

File

Number 

 

Carry

Forward 

Initial

effective 

date

  Filing Fee
Previously
Paid In
Connection
with Unsold
Securities to
be Carried
Forward
 
Newly Registered Securities
                         

Fees to Be

Paid

  Equity  

Common Stock,

par value $0.00001

per share

  —    (1)   (2)     —    —           
                         
    Equity  

Preferred Stock,

par value $0.00001

per share

  —    (1)   (2)     —    —           
                         
    Debt   Debt Securities   —    (1)   (2)     —    —           
                         
    Other   Warrants   —    (1)   (2)     —    —           
                         
    Other   Units   —    (1)   (2)     —    —           
                         
   

Unallocated 

(Universal

Shelf)

 

Common Stock,

par value $0.00001

per share

 

Rule

457(o)

  (1)   (2)   $300,000,000(3)   0.00015310    $45,930           
                         

Fees

Previously

Paid

  —      —    —    —    —    —    —    —           
 
Carry Forward Securities
                         

Carry

Forward

Securities

  —    —    —    —      —        —    —    —    — 
                   
    Total Offering Amounts      $300,000,000(3)   0.00015310    $45,930           
                   
    Total Fees Previously Paid          —           
                   
    Total Fee Offsets          —           
                   
    Net Fee Due                $45,930                 

 

(1)

There are being registered hereunder such indeterminate number of shares of common stock and preferred stock, such indeterminate principal amount of debt securities, and such indeterminate number of warrants to purchase common stock, preferred stock or debt securities as shall have an aggregate initial offering price not to exceed $300,000,000. Any securities registered hereunder may be sold separately or together with other securities registered hereunder. The securities registered also include such indeterminate amounts and numbers of common stock, preferred stock, and debt securities as may be issued upon conversion of or exchange for preferred stock or debt securities that provide for conversion or exchange, upon exercise of warrants or pursuant to the antidilution provisions of any such securities. In addition, pursuant to Rule 416 under the Securities Act of 1933, as amended, or the Securities Act, the shares being registered hereunder include such indeterminate number of shares of common stock and preferred stock as may be issuable with respect to the shares being registered hereunder as a result of stock splits, stock dividends or similar transactions.

(2)

The proposed maximum aggregate offering price per unit will be determined from time to time by the Registrant in connection with the issuance by the registrant of the securities registered hereunder and is not specified as to each class of security pursuant to General Instruction II.D of Form S-3 under the Securities Act.

(3)

Estimated solely for purposes of calculating the registration fee pursuant to Rule 457(o) under the Securities Act. The $300,000,000 of securities registered pursuant to this registration statement includes $100,000,000 of Common Stock that may be issued and sold under a certain sales agreement with Jefferies LLC. Upon termination of the sales agreement, any portion of the $100,000,000 included in the sales agreement prospectus supplement that is not sold pursuant to the sales agreement will be available for sale in other offerings pursuant to the base prospectus and a corresponding prospectus supplement, and if no shares are sold under the sales agreement, the full $100,000,000 of securities may be sold in other offerings pursuant to the base prospectus and a corresponding prospectus supplement.